Planta Med 2017; 83(03/04): 232-238
DOI: 10.1055/s-0042-111825
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

The Plant-Derived Naphthoquinone Droserone Inhibits In Vitro Measles Virus Infection

Christina Lieberherr*
1   Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany
,
Guoliang Zhang*
2   Institute of Organic Chemistry, University of Würzburg, Würzburg, Germany
3   Present address: Shanghai Huilun Life Science & Technology Co., Ltd., Shanghai, P. R. China
,
Anika Grafen
1   Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany
,
Katrin Singethan
1   Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany
4   Present address: Institute for Virology, München, Germany
,
Sabine Kendl
1   Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany
,
Valentin Vogt
1   Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany
,
Jonathan Maier
2   Institute of Organic Chemistry, University of Würzburg, Würzburg, Germany
,
Gerhard Bringmann
2   Institute of Organic Chemistry, University of Würzburg, Würzburg, Germany
,
Jürgen Schneider-Schaulies
1   Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 11. Januar 2016
revised 22. Juni 2016

accepted 02. Juli 2016

Publikationsdatum:
15. Juli 2016 (online)

Abstract

The naphthoquinone droserone (1) is a natural product occurring in dicotyledonous plants. We have now observed that the addition of 1 during infection of tissue culture cells with measles virus considerably reduced the infection. Interestingly, the infection was inhibited only when droserone (1) was added during virus entry, but not when added to the cells prior to virus uptake or after virus uptake. These findings suggest that 1 interacts with viral particles to reduce infectivity. The formation of progeny measles virus particles was inhibited to 50 % by droserone (1) at a concentration (IC50) of approximately 2 µM with a half-maximal cytotoxicity (CC50) of about 60 µM for Vero cells. Other tested naphthoquinone derivatives, among them the likewise natural plumbagin (2), but also synthetic analogs, were either more cytotoxic or not as effective as 1. Thus, our data do not support the development of naphthoquinone derivatives into antiviral compounds, but suggest that they may be interesting research tools to study measles virus entry into cells.

* These authors contributed equally to this manuscript.


Supporting Information

 
  • References

  • 1 Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406: 893-897
  • 2 Erlenhoefer C, Wurzer WJ, Löffler S, Schneider-Schaulies S, ter Meulen V, Schneider-Schaulies J. CD150 (SLAM) is a receptor for measles virus, but is not involved in viral contact-mediated proliferation inhibition. J Virol 2001; 75: 4499-4505
  • 3 De Swart RL, Ludlow M, de Witte L, Yanagi Y, van Amerongen G, McQuaid S, Yüksel S, Geijtenbeek TBH, Duprex WP, Osterhaus ADME. Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 2007; 3: e178
  • 4 Muhlebach MD, Mateo M, Sinn PL, Prufer S, Uhlig KM, Leonard VH, Navaratnarajah CK, Frenzke M, Wong XX, Sawatsky B, Ramachandran S, McCray Jr. PB, Cichutek K, von Messling V, Lopez M, Cattaneo R. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011; 480: 530-533
  • 5 Noyce RS, Bondre DG, Ha MN, Lin LT, Sisson G, Tsao MS, Richardson CD. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog 2011; 7: e1002240
  • 6 Takeda M, Tahara M, Nagata N, Seki F. Wild-type measles virus is intrinsically dual-tropic. Front Microbiol 2011; 2: 279
  • 7 Ludlow M, Allen I, Schneider-Schaulies J. Systemic spread of measles virus: overcoming the epithelial and endothelial barriers. Thromb Haemost 2009; 102: 1050-1056
  • 8 Schneider-Schaulies S, Schneider-Schaulies J. Measles virus-induced immunosuppression. Curr Top Microbiol Immunol 2009; 330: 243-269
  • 9 Duclos P, Ward BJ. Measles vaccines: a review of adverse events. Drug Saf 1998; 6: 435-454
  • 10 Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 2015; 348: 694-699
  • 11 Kabir Z, Long J, Reddaiah VP, Kevany J, Kapoor SK. Non-specific effect of measles vaccination on overall child mortality in an area of rural India with high vaccination coverage: a population-based case-control study. Bull World Health Organ 2003; 81: 244-250
  • 12 Bringmann G, Rüdenauer S, Irmer A, Bruhn T, Brun R, Heimberger T, Stühmer T, Bargou R, Chatterjee M. Antitumoral and antileishmanial dioncoquinones and ancistroquinones from cell cultures of Triphyophyllum peltatum (Dioncophyllaceae) and Ancistrocladus abbreviatus (Ancistrocladaceae). Phytochemistry 2008; 69: 2501-2509
  • 13 Bringmann G, Feineis D. Stress-related polyketide metabolism of Dioncophyllaceae and Ancistrocladaceae. J Exp Bot 2001; 52: 2015-2022
  • 14 Bringmann G, Rischer H, Wohlfarth M, Schlauer J, Aké Assi L. Droserone from cell cultures of Triphyophyllum peltatum (Dioncophyllaceae) and its biosynthetic origin. Phytochemistry 2000; 53: 339-343
  • 15 Babula P, Adam V, Havel L, Kizek R. Noteworthy secondary metabolites naphthoquinones – their occurrence, pharmacological properties and analysis. Curr Pharm Anal 2009; 5: 47-68
  • 16 Peters K, Peters E-M, von Schnering HG, Bringmann G, Kehr C, Haller RD, Bär S, Isahakia MA, Robertson SA. Crystal structure of droserone in ‘biogenic crystals’ found under the stem bark of Ancistrocladus robertsoniorum . Z Kristallogr 1995; 210: 290-291
  • 17 Bringmann G, François G, Aké Assi L, Schlauer J. The alkaloids of Triphyophyllum peltatum (Dioncophyllaceae). Chimia (Aarau) 1998; 52: 18-28
  • 18 Padhye S, Dandawate P, Yusufi M, Ahmad A, Sarkar FH. Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev 2012; 32: 1131-1158
  • 19 Raj G, Kurup R, Hussain AA, Baby S. Distribution of naphthoquinones, plumbagin, droserone, and 5-O-methyl droserone in chitin-induced and uninduced Nepenthes khasiana: molecular events in prey capture. J Exp Bot 2011; 62: 5429-5436
  • 20 Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M, Takeuchi K, Yanagi Y. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 2002; 76: 6743-6749
  • 21 Plemper RK, Erlandson KJ, Lakdawala AS, Sun A, Prussia A, Boonsombat J, Aki-Sener E, Yalcin I, Yildiz I, Temiz-Arpaci O, Tekiner B, Liotta DC, Snyder JP, Compans RW. A target site for template-based design of measles virus entry inhibitors. Proc Natl Acad Sci U S A 2004; 101: 5628-5633
  • 22 Plemper RK, Doyle J, Sun A, Prussia A, Cheng LT, Rota PA, Liotta DC, Snyder JP, Compans RW. Design of a small-molecule entry inhibitor with activity against primary measles virus strains. Antimicrob Agents Chemother 2005; 49: 3755-3761
  • 23 Sun A, Prussia A, Zhan W, Murray EE, Doyle J, Cheng LT, Yoon JJ, Radchenko EV, Palyulin VA, Compans RW, Liotta DC, Plemper RK, Snyder JP. Nonpeptide inhibitors of measles virus entry. J Med Chem 2006; 49: 5080-5092
  • 24 Singethan K, Hiltensperger G, Kendl S, Wohlfahrt J, Plattet P, Holzgrabe U, Schneider-Schaulies J. N-(3-Cyanophenyl)-2-phenylacetamide, an effective inhibitor of morbillivirus-induced membrane fusion with low cytotoxicity. J Gen Virol 2010; 91: 2762-2772
  • 25 Yamazaki S. Chromium (VI) oxide-catalyzed oxidation of arenes with periodic acid. Tetrahedron Lett 2001; 42: 3355-3357
  • 26 Bringmann G, Zhang G, Hager A, Moos M, Irmer A, Bargou R, Chatterjee M. Anti-tumoral activities of dioncoquinones B and C and related naphthoquinones gained from total synthesis or isolation from plants. Eur J Med Chem 2011; 46: 5778-5789
  • 27 Wurm G, Goeßler B. Untersuchung an 1,4-Naphthochinonen, 18. Mitt.: 6-Methyl- und 3,6-Dimethylplumbagin. Arch Pharm 1989; 322: 489-491